198 related articles for article (PubMed ID: 31115928)
21. Novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives containing hydrazone fragment as potent and selective anticancer agents.
Xu C; Zhou W; Dong G; Qiao H; Peng J; Jia P; Li Y; Liu H; Sun K; Zhao W
Bioorg Chem; 2020 Dec; 105():104424. PubMed ID: 33161253
[TBL] [Abstract][Full Text] [Related]
22. New Anthranilic Acid Hydrazones as Fenamate Isosteres: Synthesis, Characterization, Molecular Docking, Dynamics & in Silico ADME, in Vitro Anti-Inflammatory and Anticancer Activity Studies.
Şenol H; Çağman Z; Gençoğlu Katmerlikaya T; Sinan Tokalı F
Chem Biodivers; 2023 Aug; 20(8):e202300773. PubMed ID: 37384873
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, cytotoxicity, and pro-apoptosis activity of etodolac hydrazide derivatives as anticancer agents.
Çıkla P; Özsavcı D; Bingöl-Özakpınar Ö; Şener A; Çevik Ö; Özbaş-Turan S; Akbuğa J; Şahin F; Küçükgüzel ŞG
Arch Pharm (Weinheim); 2013 May; 346(5):367-79. PubMed ID: 23609809
[TBL] [Abstract][Full Text] [Related]
24. Molecular hybrid design, synthesis, in vitro and in vivo anticancer evaluation, and mechanism of action of N-acylhydrazone linked, heterobivalent β-carbolines.
Guo L; Chen X; Chen W; Ma Q; Fan W; Zhang J; Dai B
Bioorg Chem; 2020 Mar; 96():103612. PubMed ID: 32007724
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, biological evaluation, drug-likeness, and in silico screening of novel benzylidene-hydrazone analogues as small molecule anticancer agents.
Alam MS; Lee DU
Arch Pharm Res; 2016 Feb; 39(2):191-201. PubMed ID: 26694484
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of novel diflunisal hydrazide-hydrazones as anti-hepatitis C virus agents and hepatocellular carcinoma inhibitors.
Şenkardeş S; Kaushik-Basu N; Durmaz İ; Manvar D; Basu A; Atalay R; Küçükgüzel ŞG
Eur J Med Chem; 2016 Jan; 108():301-308. PubMed ID: 26695731
[TBL] [Abstract][Full Text] [Related]
27. Analogue-based design, synthesis and biological evaluation of 3-substituted-(methylenehydrazono)indolin-2-ones as anticancer agents.
Dweedar HE; Mahrous H; Ibrahim HS; Abdel-Aziz HA
Eur J Med Chem; 2014 May; 78():275-80. PubMed ID: 24686014
[TBL] [Abstract][Full Text] [Related]
28. Indole-based hydrazide-hydrazones and 4-thiazolidinones: synthesis and evaluation as antitubercular and anticancer agents.
Cihan-Üstündağ G; Şatana D; Özhan G; Çapan G
J Enzyme Inhib Med Chem; 2016; 31(3):369-80. PubMed ID: 25910087
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, potential antitumor activity, cell cycle analysis, and multitarget mechanisms of novel hydrazones incorporating a 4-methylsulfonylbenzene scaffold: a molecular docking study.
Abdel-Aziz AA; El-Azab AS; AlSaif NA; Obaidullah AJ; Al-Obaid AM; Al-Suwaidan IA
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1521-1539. PubMed ID: 34266349
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and in vitro bioactivity study of new hydrazide-hydrazones of 5-bromo-2-iodobenzoic acid.
Popiołek Ł; Patrejko P; Gawrońska-Grzywacz M; Biernasiuk A; Berecka-Rycerz A; Natorska-Chomicka D; Piątkowska-Chmiel I; Gumieniczek A; Dudka J; Wujec M
Biomed Pharmacother; 2020 Oct; 130():110526. PubMed ID: 32693180
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and molecular docking studies of novel N-benzenesulfonyl-1,2,3,4-tetrahydroisoquinoline-based triazoles with potential anticancer activity.
Pingaew R; Mandi P; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Eur J Med Chem; 2014 Jun; 81():192-203. PubMed ID: 24836071
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and bioevaluation and doking study of 1H-pyrrolo[2,3-b]pyridine derivatives bearing aromatic hydrazone moiety as c-Met inhibitors.
Wang W; Xu S; Duan Y; Liu X; Li X; Wang C; Zhao B; Zheng P; Zhu W
Eur J Med Chem; 2018 Feb; 145():315-327. PubMed ID: 29331754
[TBL] [Abstract][Full Text] [Related]
33. Bis-isatin hydrazones with novel linkers: Synthesis and biological evaluation as cytotoxic agents.
Ibrahim HS; Abou-Seri SM; Ismail NSM; Elaasser MM; Aly MH; Abdel-Aziz HA
Eur J Med Chem; 2016 Jan; 108():415-422. PubMed ID: 26706352
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, computational quantum chemical study, in silico ADMET and molecular docking analysis, in vitro biological evaluation of a novel sulfur heterocyclic thiophene derivative containing 1,2,3-triazole and pyridine moieties as a potential human topoisomerase IIα inhibiting anticancer agent.
Murugavel S; Ravikumar C; Jaabil G; Alagusundaram P
Comput Biol Chem; 2019 Apr; 79():73-82. PubMed ID: 30731361
[TBL] [Abstract][Full Text] [Related]
35. Design, Synthesis, and Cytotoxicity of Novel 2,4,6-Trisubstituted 1,3,5- triazines Bearing Aryl Hydrazone Moiety as Potent Antitumor Agent.
Wang L; Zhao S; Bao G; Zhang Y; Xi S; Zhou G; Zhai X; Gong P
Med Chem; 2016; 12(7):621-630. PubMed ID: 26732116
[TBL] [Abstract][Full Text] [Related]
36. Antiproliferative Activity of 8-methoxy Ciprofloxacin-Hydrozone/Acylhydrazone Scaffolds.
Wang LP; Xu Z; Deng GY; Xu SL
Curr Top Med Chem; 2020; 20(21):1911-1915. PubMed ID: 32493190
[TBL] [Abstract][Full Text] [Related]
37. Microwave-Assisted Facile Synthesis, Anticancer Evaluation and Docking Study of N-((5-(Substituted methylene amino)-1,3,4-thiadiazol-2-yl)methyl) Benzamide Derivatives.
Tiwari SV; Siddiqui S; Seijas JA; Vazquez-Tato MP; Sarkate AP; Lokwani DK; Nikalje APG
Molecules; 2017 Jun; 22(6):. PubMed ID: 28617341
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of New Hydrazone Derivatives and Evaluation of their Efficacy as Proliferation Inhibitors in Human Cancer Cells.
Świątek P; Saczko J; Rembiałkowska N; Kulbacka J
Med Chem; 2019; 15(8):903-910. PubMed ID: 30686263
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and evaluation of pyridinium-hydrazone derivatives as potential antitumoral agents.
Parlar S; Erzurumlu Y; Ilhan R; Ballar Kırmızıbayrak P; Alptüzün V; Erciyas E
Chem Biol Drug Des; 2018 Jul; 92(1):1198-1205. PubMed ID: 29415336
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, anticancer, and docking studies of salicyl-hydrazone analogues: A novel series of small potent tropomyosin receptor kinase A inhibitors.
Alam MS; Choi SU; Lee DU
Bioorg Med Chem; 2017 Jan; 25(1):389-396. PubMed ID: 27856237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]